UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 21.729

Sortiert nach

The impact of sport on health status, psychological well-being and physical performance of adults with haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-07, Vol.22 (4), p.521-530

2016

Volltextzugriff (PDF)

Evaluation of the use of global haemostasis assays to monitor treatment in factor XI deficiency

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-03, Vol.23 (2), p.273-283

2017

Volltextzugriff (PDF)

The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study

Thrombosis and haemostasis, 1997-12, Vol.78 (6), p.1463

1997

Volltextzugriff (PDF)

Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive Committee

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-05, Vol.24 (3), p.344-347

2018

Volltextzugriff (PDF)

The diagnosis and management of factor VIII and IX inhibitors : A guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO)

British journal of haematology, 2000-10, Vol.111 (1), p.78-90

2000

Volltextzugriff (PDF)

Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference

Haemophilia : the official journal of the World Federation of Hemophilia, 2006-12, Vol.12 (s6), p.1-7

2006

Volltextzugriff (PDF)

The haemtrack home therapy reporting system: Design, implementation, strengths and weaknesses: A report from UK Haemophilia Centre Doctors Organisation

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-09, Vol.23 (5), p.728-735

2017

Volltextzugriff (PDF)

Development of resistance to activated protein C during pregnancy

British journal of haematology, 1995-07, Vol.90 (3), p.725-727

1995

Volltextzugriff (PDF)

Purchasing factor concentrates in the 21st century through competitive tendering

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-09, Vol.19 (5), p.660-667

Hay, C. R. M.

2013

Volltextzugriff (PDF)

The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population

British journal of haematology, 1997-08, Vol.98 (2), p.353-355

1997

Volltextzugriff (PDF)

EUHASS: The European Haemophilia Safety Surveillance system

Thrombosis research, 2011, Vol.127, p.S22-S25

2011

Volltextzugriff (PDF)

Use of the UKHCDO Database for a postmarketing surveillance study of different doses of recombinant factor VIIa in haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-05, Vol.23 (3), p.376-382

2017

Volltextzugriff (PDF)

The immunogenicity of ReFacto AF (moroctocog alfa AF‐CC) in previously untreated patients with haemophilia A in the United Kingdom

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-11, Vol.24 (6), p.896-901

2018

Volltextzugriff (PDF)

Weekly recombinant FIX prophylaxis for severe haemophilia B in normal clinical practice: data from UKHCDO and Finland

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-05, Vol.23 (3), p.e240-e243

2017

Volltextzugriff (PDF)

The incidence of factor VIII inhibitors in severe haemophilia A following a major switch from full-length to B-domain-deleted factor VIII: a prospective cohort comparison

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-03, Vol.21 (2), p.219-226

2015

Volltextzugriff (PDF)

Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-01, Vol.24 (1), p.104-112

2018

Volltextzugriff (PDF)

The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977–99

Journal of thrombosis and haemostasis, 2004-07, Vol.2 (7), p.1047-1054

2004

Volltextzugriff (PDF)

Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study

Haemophilia : the official journal of the World Federation of Hemophilia, 2015-09, Vol.21 (5), p.e369-e374

2015

Volltextzugriff (PDF)

Efficacy and safety of Nuwiq® (human‐cl rhFVIII) in patients with severe haemophilia A undergoing surgical procedures

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-01, Vol.24 (1), p.70-76

2018

Volltextzugriff (PDF)

Prophylaxis in adults with haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2007-09, Vol.13 (s2), p.10-15

HAY, C. R. M.

2007

Volltextzugriff (PDF)

Tamoxifen for recurrent bleeds due to angiodysplasia in von Willebrand's disease

Haemophilia : the official journal of the World Federation of Hemophilia, 2013-09, Vol.19 (5), p.e313-e315

2013

Volltextzugriff (PDF)

Evaluation of the use of rotational thromboelastometry in the assessment of FXI deficency

Haemophilia : the official journal of the World Federation of Hemophilia, 2017-05, Vol.23 (3), p.449-457

2017

Volltextzugriff (PDF)

The international immune tolerance study: a multicenter prospective randomized trial in progress

Journal of thrombosis and haemostasis, 2006-10, Vol.4 (10), p.2271-2273

2006

Volltextzugriff (PDF)

How I treat inhibitors in haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2012-07, Vol.18 (s4), p.48-53

2012

Volltextzugriff (PDF)

In vitro comparison of the effect of two factor XI (FXI) concentrates on thrombin generation in major FXI deficiency

Haemophilia : the official journal of the World Federation of Hemophilia, 2016-05, Vol.22 (3), p.403-410

2016

Volltextzugriff (PDF)

1 – 25 von 21.729

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15.144)
Mit Volltextzugriff
(13.854)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Spanisch
(16.861)
Englisch
(5.217)
Portugiesisch
(3.221)
Japanisch
(959)
Katalanisch
(64)
Französisch
(47)
Deutsch
(17)
Norwegisch
(8)
Hebräisch
(3)
Estnisch
(2)
Italienisch
(1)
Russisch
(1)

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Free E-Journals
(13.664)
MEDLINE
(7.575)
Elsevier ScienceDirect Journals Complete
(7.132)
Ingenta
(6.706)
IngentaConnect Journals
(3.833)
Journals@Ovid Complete
(1.305)
Publisher website
(875)
Wiley Online Library Journals Frontfile Complete
(635)
Wiley Online Library Full Collection 2018
(469)
Springer Nature - Complete Springer Journals
(413)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(411)
Jstor Complete Legacy
(346)
Oxford Journals
(265)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(229)
EBSCOhost Business Source Ultimate
(229)
Nexis Uni
(171)
Nature
(145)
EBSCOhost Psychology and Behavioral Sciences Collection
(142)
Oxford Journals 2020 Medicine
(135)
Taylor & Francis Journals Complete
(118)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Revista Clínica Espanõla
(885)
Medicina Clínica
(560)
Actas Dermo-Sifiliográficas
(448)
Revista De Neurologiá
(436)
Anales De Pediatría
(419)
Revista Medíca De Chile
(378)
Actas Urologicas Españolas
(326)
Revista Española De Anestesiología Y Reanimación
(297)
Prensa Médica Argentina
(288)
Archivos De Bronconeumología
(278)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The impact of sport on health status, psychological well-being and physical performance of adults with haemophilia

Evaluation of the use of global haemostasis assays to monitor treatment in factor XI deficiency

The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study

Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive Committee

The diagnosis and management of factor VIII and IX inhibitors : A guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO)

Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference

The haemtrack home therapy reporting system: Design, implementation, strengths and weaknesses: A report from UK Haemophilia Centre Doctors Organisation

Development of resistance to activated protein C during pregnancy

Purchasing factor concentrates in the 21st century through competitive tendering

The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population

EUHASS: The European Haemophilia Safety Surveillance system

Use of the UKHCDO Database for a postmarketing surveillance study of different doses of recombinant factor VIIa in haemophilia

The immunogenicity of ReFacto AF (moroctocog alfa AF‐CC) in previously untreated patients with haemophilia A in the United Kingdom

Weekly recombinant FIX prophylaxis for severe haemophilia B in normal clinical practice: data from UKHCDO and Finland

The incidence of factor VIII inhibitors in severe haemophilia A following a major switch from full-length to B-domain-deleted factor VIII: a prospective cohort comparison

Pharmacokinetics, safety and efficacy of a recombinant factor IX product, trenonacog alfa in previously treated haemophilia B patients

The incidence of factor VIII and factor IX inhibitors in the hemophilia population of the UK and their effect on subsequent mortality, 1977–99

Central venous access device (CVAD) complications in Haemophilia with inhibitors undergoing immune tolerance induction: Lessons from the international immune tolerance study

Efficacy and safety of Nuwiq® (human‐cl rhFVIII) in patients with severe haemophilia A undergoing surgical procedures

Prophylaxis in adults with haemophilia

Tamoxifen for recurrent bleeds due to angiodysplasia in von Willebrand's disease

Evaluation of the use of rotational thromboelastometry in the assessment of FXI deficency

The international immune tolerance study: a multicenter prospective randomized trial in progress

How I treat inhibitors in haemophilia

In vitro comparison of the effect of two factor XI (FXI) concentrates on thrombin generation in major FXI deficiency

Suchergebnisse filtern